Auriga Research

Leading Indian CRO

  • Home
    • About Us
    • Arbro Group
  • Testing Services
    • Pharmaceutical Testing
    • Food Testing
    • Herbal Testing
    • Cosmetics Testing
    • Medical Device Testing
    • Water Testing
    • Sensory Analysis
    • Inspection & Sampling
    • Construction & Building Material Testing Lab
    • Shelf Life Studies
    • Analytical Research
      • Characterization
      • Method Development
      • Method Validation
      • Stability studies
      • Impurity Profiling
      • Routine Analysis
  • Clinical Trials
    • Clinical Trial Regulation in India: Recent Updates
    • Feasibility Studies
    • Cosmetic Clinical Trial
    • Medical Writing
    • Investigator Selection
    • Project Management
    • Site Management
    • Monitoring
    • Clinical Trial Formulation
      • Clinical Trial Services (Phase I to IV)
    • Laboratory Services
      • Accomplishments
  • Bioequivalence Studies
    • Bioavailability & Bioequivalences Studies
    • Bioanalytical Methods
    • Clinical Facilities
    • Project Management
    • Medical Writing
    • Regulatory Assistance
    • Biowaiver Monograph
    • RLD Sourcing
    • Volunteers with us
  • Certification Divison
    • Overview
    • Services
      • QCI Scheme for India HACCP and India GHP
      • FSMS/ISO 22000:2018
    • Quality Policy
    • Complaint Redressal
      • Procedures – IndiaGHP & IndiaHACCP
      • FSMS/ISO 22000:2018
  • COVID 19 Testing
  • Free E-courses
    • Ethics Committee Accreditation and Registration in India
    • Analytical Training
    • Free E-Course on Bio-Equivalence Studies
    • New Drug Approval in India: A free online course
    • Free e-Course : Regulation on Medical Devices and Diagnostic Kits in India
  • Contact Us
    • Current Openings
    • Business Queries
    • Investigator Registration
    • Partnering With Us
  • News
    • Workshops
    • Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices
You are here: Home / Clinical Trial Regulation in India: Recent Updates

Clinical Trial Regulation in India: Recent Updates

The Central Drugs Standard Control Organization (CDSCO) in India has issued number of guidelines to strengthen clinical trial regulations in India after January 2013. We have tried to compile these guideline in this mailer to have overall understanding on the same.

The recent amendments in schedule Y are

  • Introduction of Rule 122DAB ­- Specifying the procedures for payment of compensation to the subjects of the trial in cases of injury or death
  • Introduction of Rule 122DAC – Specifying various conditions for conduct and inspection of clinical trials
  • Introduction of Rule 122DD – Specifying the detailed guidelines for registration of Ethics Committee
  • Drugs and Cosmetics (Amendment) Bill 2013 – Yet to be introduced

Audio-Visual Recording of Consent

  • Gazette Notification for Audio-Visual recording of informed consent
  • Audio-Video recording of informed consent has become mandatory

Dr Ranjit Roy Chaudhary Report

  • Recently Dr Ranjit Roy Chaudhary committee has submitted reports which discuss about practices for conducive environment for growth of clinical trial industry also meeting the regulatory standards.
  • Actions on the recommendations of prof. Ranjit Roy Chaudhury expert committee to formulate policy and guidelines for approval of new drugs, clinical trials and banning of drugs

SAE Reporting and Compensation

The process of SAEs reporting in case of injury/death has been revised in recent Schedule Y amendments and below is required information to be submitted along with the SAEs report.

  • System of Pre-screening for submission of reports of SAEs to CDSCO
  • Panel of expert for reviewing of SAE of death
  • Formula to determine the quantum of compensation in the cases of clinical trial related serious adverse events (SAEs) of deaths occurring during clinical trials

Ethics Committee Registration

  • System for the pre-screening of the applications for registration of ethics committees
  • IEC in respect of periodic review of ongoing clinical trials
  • List of Registered Ethics Committees – State Wise

Pre-screening Checklist for Clinical Trial and New Drugs Applications

On behalf of “People for the Advancement of Clinical Research – India”, who have taken the initiative to revive the Clinical Research conduct in India, we would like to request all the Clinical Research Professionals to read the petition, and if you agree with the cause, please sign the petition here

  • Read here Supreme Court Proceeding of 30th Sept 2013

Recent Circular related to clinical trials

  • Furnishing information with respect to financial support to investigator – should be part of clinical trial application
  • Monitoring of Clinical Trial to all Zonal Offices

Articles on recent regulation for detail reading

  • Clinical trials: Are we writing-off this noble profession?
  • Recent Regulatory Amendment in Schedule Y: Impact on Bioequivalence Studies Conducted In India
  • Recent Changes to Clinical Trial Regulation in India: Focus on Serious Adverse Events, Compensation and Registration of Ethics Committees

We would also like to update our subscribers on the followings

  1. After conducting three successful events on recent clinical trial regulation we have created a group “Clinical Research Events in India”. Click here to join the group
  2. Telecast of our recent conference On ‘Adapting to the Current Regulatory Challenges in conduct of Clinical Research – Focus on Sites and Ethics Committees can be viewed on CARE WORLD TV on following timings -27th Nov’13 Wednesday @ 10:45 hrs, 29th Nov’13 [email protected] 14:50 hrs, 1st Dec’13 [email protected] 20:17 hrs. To Watch Care World Live: http://www.careworldtv.com/live/
  3. Our training partner SenseCR has organized a workshop titled as “Case study based advanced GCP Workshop” on 29th Nov, 2013 at Bawa International Hotel, Near Domestic Airport, Mumbai. Please contact Shilpa Garg at [email protected]

To Subscribe to our Newsletter – Please Click here 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Quick Query

News

  • Commencement of new Analytical laboratory
  • Oryzanol Testing in Mustard Oil Using HPLC Method- Enforcement by FSSAI
  • CIIE, Shanghai, China (5th-10th November 2019) Booth No M5, at Hall 7.1 H
  • Ethics Committee Accreditation and Registration in India: Introduction
  • DTAB recommends not using vegetarian indicator on cellulose capsules and prohibits use of PET bottles for packaging pharmaceutical drugs
  • A report by AIIH&PH on the use of PET or plastic bottles for packaging of pharmaceutical preparations, soft drinks and alcohol
  • Arbro Pharma & Auriga Research Exhibiting in ASIA LABEX 2015
  • Conference on Challenges in Design and Conduct of Clinical Trials of Medical Devices
  • Great News! Auriga BE Center is now approved by NPCB, Malaysia
  • Conference on Accreditation of Sites, Investigators and Ethics Committees

Tag Cloud

Analytical testing lab Approved Drugs Clinical Research Compensation Dcgi Drug Approved Drug List Fdcs Fixed Dose Combination Informed Consent Process Mustard oil testing Not Approved Pharmaceutical testing Webinar

Socialize with us!

  • Facebook
  • Google+
  • LinkedIn
  • Twitter

Signup for our mailing list!






Contact Us!

Auriga Research Pvt. Ltd. (A Contract Research Organization)
3/15 Kirti Nagar Industrial Area
New Delhi
India 110015
e-mail - [email protected]
Telephone - +91 11 45754546

Copyright © 2021 Auriga Research Pvt. Ltd.

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.